Specialty Pharmacy Times: CMS 340B Reimbursement Cuts Cause Big Pharma Profits While Underserved Patients Lose
Posted on January 3, 2018 |
“As you and your readers may now be aware, the 340B Drug Pricing Program has been under siege for the past couple months. The program requires drug manufacturers to provide ...